In vitro anticancer activity, toxicity and structure–activity relationships of phyllostictine A, a natural oxazatricycloalkenone produced by the fungus Phyllosticta cirsii

The in vitro anticancer activity and toxicity of phyllostictine A, a novel oxazatricycloalkenone recently isolated from a plant-pathogenic fungus ( Phyllosticta cirsii) was characterized in six normal and five cancer cell lines. Phyllostictine A displays in vitro growth-inhibitory activity both in n...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Toxicology and applied pharmacology 2011-07, Vol.254 (1), p.8-17
Hauptverfasser: Le Calvé, Benjamin, Lallemand, Benjamin, Perrone, Carmen, Lenglet, Gaëlle, Depauw, Sabine, Van Goietsenoven, Gwendoline, Bury, Marina, Vurro, Maurizio, Herphelin, Françoise, Andolfi, Anna, Zonno, Maria Chiara, Mathieu, Véronique, Dufrasne, François, Van Antwerpen, Pierre, Poumay, Yves, David-Cordonnier, Marie-Hélène, Evidente, Antonio, Kiss, Robert
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 17
container_issue 1
container_start_page 8
container_title Toxicology and applied pharmacology
container_volume 254
creator Le Calvé, Benjamin
Lallemand, Benjamin
Perrone, Carmen
Lenglet, Gaëlle
Depauw, Sabine
Van Goietsenoven, Gwendoline
Bury, Marina
Vurro, Maurizio
Herphelin, Françoise
Andolfi, Anna
Zonno, Maria Chiara
Mathieu, Véronique
Dufrasne, François
Van Antwerpen, Pierre
Poumay, Yves
David-Cordonnier, Marie-Hélène
Evidente, Antonio
Kiss, Robert
description The in vitro anticancer activity and toxicity of phyllostictine A, a novel oxazatricycloalkenone recently isolated from a plant-pathogenic fungus ( Phyllosticta cirsii) was characterized in six normal and five cancer cell lines. Phyllostictine A displays in vitro growth-inhibitory activity both in normal and cancer cells without actual bioselectivity, while proliferating cells appear significantly more sensitive to phyllostictine A than non-proliferating ones. The main mechanism of action by which phyllostictine displays cytotoxic effects in cancer cells does not seem to relate to a direct activation of apoptosis. In the same manner, phyllostictine A seems not to bind or bond with DNA as part of its mechanism of action. In contrast, phyllostictine A strongly reacts with GSH, which is a bionucleophile. The experimental data from the present study are in favor of a bonding process between GSH and phyllostictine A to form a complex though Michael attack at C=C bond at the acrylamide-like system. Considering the data obtained, two new hemisynthesized phyllostictine A derivatives together with three other natural phyllostictines (B, C and D) were also tested in vitro in five cancer cell lines. Compared to phyllostictine A, the two derivatives displayed a higher, phyllostictines B and D a lower, and phyllostictine C an almost equal, growth-inhibitory activity, respectively. These results led us to propose preliminary conclusions in terms of the structure–activity relationship (SAR) analyses for the anticancer activity of phyllostictine A and its related compounds, at least in vitro.
doi_str_mv 10.1016/j.taap.2011.03.027
format Article
fullrecord <record><control><sourceid>proquest_osti_</sourceid><recordid>TN_cdi_osti_scitechconnect_21587778</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0041008X11001311</els_id><sourcerecordid>899151666</sourcerecordid><originalsourceid>FETCH-LOGICAL-c415t-446a641d587137925777e9ab82bffceacb898bc7ea5a78caa6dce1c65d4a49873</originalsourceid><addsrcrecordid>eNp9kc1u1DAUhSMEokPhBVggSyzYNMFOnMSR2FQVP5UqwQIkdtbNzQ3jIWMPtlM1rHgHnoOX4klwNC3sWNmyv3N8fU6WPRW8EFw0L3dFBDgUJRei4FXBy_ZethG8a3JeVdX9bMO5FDnn6vNJ9iiEHee8k1I8zE5KUXPZ1vUm-3Vp2bWJ3jGw0SBYJM8Ao0mHyxmL7sZg2qXbgYXoZ4yzp98_ft4hzNME0TgbtuYQmBvZYbtMkwvJLBpL7PyMAbOQZDAxdwPfIXqDC04Opq9kXUIO3g0z0sD6hcUtsXG2X-bAPvwzAobGB2MeZw9GmAI9uV1Ps09vXn-8eJdfvX97eXF-laMUdcylbKCRYqhVK6q2K-u2bamDXpX9OCIB9qpTPbYENbQKAZoBSWBTDxJkp9rqNHt-9F2f1yElQLhFZy1h1Ck8lQxVol4cqfSBbzOFqPcmIE0TWHJz0KrrRC2apklkeSTRuxA8jfrgzR78ogXXa5d6p9cu9dql5pVOXSbRs1v7ud_T8FdyV14CXh0BSlFcG_LrpJQaHIxfBx2c-Z__H2SItvE</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>899151666</pqid></control><display><type>article</type><title>In vitro anticancer activity, toxicity and structure–activity relationships of phyllostictine A, a natural oxazatricycloalkenone produced by the fungus Phyllosticta cirsii</title><source>MEDLINE</source><source>Access via ScienceDirect (Elsevier)</source><creator>Le Calvé, Benjamin ; Lallemand, Benjamin ; Perrone, Carmen ; Lenglet, Gaëlle ; Depauw, Sabine ; Van Goietsenoven, Gwendoline ; Bury, Marina ; Vurro, Maurizio ; Herphelin, Françoise ; Andolfi, Anna ; Zonno, Maria Chiara ; Mathieu, Véronique ; Dufrasne, François ; Van Antwerpen, Pierre ; Poumay, Yves ; David-Cordonnier, Marie-Hélène ; Evidente, Antonio ; Kiss, Robert</creator><creatorcontrib>Le Calvé, Benjamin ; Lallemand, Benjamin ; Perrone, Carmen ; Lenglet, Gaëlle ; Depauw, Sabine ; Van Goietsenoven, Gwendoline ; Bury, Marina ; Vurro, Maurizio ; Herphelin, Françoise ; Andolfi, Anna ; Zonno, Maria Chiara ; Mathieu, Véronique ; Dufrasne, François ; Van Antwerpen, Pierre ; Poumay, Yves ; David-Cordonnier, Marie-Hélène ; Evidente, Antonio ; Kiss, Robert</creatorcontrib><description>The in vitro anticancer activity and toxicity of phyllostictine A, a novel oxazatricycloalkenone recently isolated from a plant-pathogenic fungus ( Phyllosticta cirsii) was characterized in six normal and five cancer cell lines. Phyllostictine A displays in vitro growth-inhibitory activity both in normal and cancer cells without actual bioselectivity, while proliferating cells appear significantly more sensitive to phyllostictine A than non-proliferating ones. The main mechanism of action by which phyllostictine displays cytotoxic effects in cancer cells does not seem to relate to a direct activation of apoptosis. In the same manner, phyllostictine A seems not to bind or bond with DNA as part of its mechanism of action. In contrast, phyllostictine A strongly reacts with GSH, which is a bionucleophile. The experimental data from the present study are in favor of a bonding process between GSH and phyllostictine A to form a complex though Michael attack at C=C bond at the acrylamide-like system. Considering the data obtained, two new hemisynthesized phyllostictine A derivatives together with three other natural phyllostictines (B, C and D) were also tested in vitro in five cancer cell lines. Compared to phyllostictine A, the two derivatives displayed a higher, phyllostictines B and D a lower, and phyllostictine C an almost equal, growth-inhibitory activity, respectively. These results led us to propose preliminary conclusions in terms of the structure–activity relationship (SAR) analyses for the anticancer activity of phyllostictine A and its related compounds, at least in vitro.</description><identifier>ISSN: 0041-008X</identifier><identifier>EISSN: 1096-0333</identifier><identifier>DOI: 10.1016/j.taap.2011.03.027</identifier><identifier>PMID: 21504755</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>60 APPLIED LIFE SCIENCES ; Alkylation - drug effects ; ANIMALS ; Antibiotics, Antineoplastic - pharmacology ; Antibiotics, Antineoplastic - toxicity ; APOPTOSIS ; Apoptosis - drug effects ; Ascomycota - metabolism ; BODY ; BROMIDES ; BROMINE COMPOUNDS ; CALVES ; Cancer cells ; CATTLE ; Cell Cycle - drug effects ; Cell death ; Cell Line ; Cell Line, Tumor ; Cell proliferation ; Chemical stability ; DESORPTION ; DICHROISM ; DISEASES ; DNA ; DNA - metabolism ; DOMESTIC ANIMALS ; DRUGS ; FUNGI ; GLIOMAS ; GLUTATHIONE ; Glutathione - metabolism ; HALIDES ; HALOGEN COMPOUNDS ; Hemisyntheses ; Heterocyclic Compounds, 3-Ring - pharmacology ; Heterocyclic Compounds, 3-Ring - toxicity ; Humans ; IN VITRO ; IONIZATION ; LUNGS ; LYMPHATIC SYSTEM ; MAMMALS ; MASS SPECTROSCOPY ; MELTING POINTS ; Microscopy, Video ; NEOPLASMS ; Neoplasms - drug therapy ; NERVOUS SYSTEM DISEASES ; Normal cells ; NUCLEIC ACIDS ; ORGANIC COMPOUNDS ; ORGANS ; PEPTIDES ; Phyllosticta ; Phyllostictines ; PHYSICAL PROPERTIES ; PLANTS ; POLYPEPTIDES ; PROTEINS ; RADIOPROTECTIVE SUBSTANCES ; RESPIRATORY SYSTEM ; RESPONSE MODIFYING FACTORS ; RUMINANTS ; SORPTION ; SPECTROSCOPY ; Structure-Activity Relationship ; STRUCTURE-ACTIVITY RELATIONSHIPS ; THERMODYNAMIC PROPERTIES ; THYMUS ; TOXICITY ; TRANSITION TEMPERATURE ; VERTEBRATES ; Videomicroscopy</subject><ispartof>Toxicology and applied pharmacology, 2011-07, Vol.254 (1), p.8-17</ispartof><rights>2011 Elsevier Inc.</rights><rights>Copyright © 2011 Elsevier Inc. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c415t-446a641d587137925777e9ab82bffceacb898bc7ea5a78caa6dce1c65d4a49873</citedby><cites>FETCH-LOGICAL-c415t-446a641d587137925777e9ab82bffceacb898bc7ea5a78caa6dce1c65d4a49873</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.taap.2011.03.027$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>230,315,781,785,886,3551,27926,27927,45997</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/21504755$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink><backlink>$$Uhttps://www.osti.gov/biblio/21587778$$D View this record in Osti.gov$$Hfree_for_read</backlink></links><search><creatorcontrib>Le Calvé, Benjamin</creatorcontrib><creatorcontrib>Lallemand, Benjamin</creatorcontrib><creatorcontrib>Perrone, Carmen</creatorcontrib><creatorcontrib>Lenglet, Gaëlle</creatorcontrib><creatorcontrib>Depauw, Sabine</creatorcontrib><creatorcontrib>Van Goietsenoven, Gwendoline</creatorcontrib><creatorcontrib>Bury, Marina</creatorcontrib><creatorcontrib>Vurro, Maurizio</creatorcontrib><creatorcontrib>Herphelin, Françoise</creatorcontrib><creatorcontrib>Andolfi, Anna</creatorcontrib><creatorcontrib>Zonno, Maria Chiara</creatorcontrib><creatorcontrib>Mathieu, Véronique</creatorcontrib><creatorcontrib>Dufrasne, François</creatorcontrib><creatorcontrib>Van Antwerpen, Pierre</creatorcontrib><creatorcontrib>Poumay, Yves</creatorcontrib><creatorcontrib>David-Cordonnier, Marie-Hélène</creatorcontrib><creatorcontrib>Evidente, Antonio</creatorcontrib><creatorcontrib>Kiss, Robert</creatorcontrib><title>In vitro anticancer activity, toxicity and structure–activity relationships of phyllostictine A, a natural oxazatricycloalkenone produced by the fungus Phyllosticta cirsii</title><title>Toxicology and applied pharmacology</title><addtitle>Toxicol Appl Pharmacol</addtitle><description>The in vitro anticancer activity and toxicity of phyllostictine A, a novel oxazatricycloalkenone recently isolated from a plant-pathogenic fungus ( Phyllosticta cirsii) was characterized in six normal and five cancer cell lines. Phyllostictine A displays in vitro growth-inhibitory activity both in normal and cancer cells without actual bioselectivity, while proliferating cells appear significantly more sensitive to phyllostictine A than non-proliferating ones. The main mechanism of action by which phyllostictine displays cytotoxic effects in cancer cells does not seem to relate to a direct activation of apoptosis. In the same manner, phyllostictine A seems not to bind or bond with DNA as part of its mechanism of action. In contrast, phyllostictine A strongly reacts with GSH, which is a bionucleophile. The experimental data from the present study are in favor of a bonding process between GSH and phyllostictine A to form a complex though Michael attack at C=C bond at the acrylamide-like system. Considering the data obtained, two new hemisynthesized phyllostictine A derivatives together with three other natural phyllostictines (B, C and D) were also tested in vitro in five cancer cell lines. Compared to phyllostictine A, the two derivatives displayed a higher, phyllostictines B and D a lower, and phyllostictine C an almost equal, growth-inhibitory activity, respectively. These results led us to propose preliminary conclusions in terms of the structure–activity relationship (SAR) analyses for the anticancer activity of phyllostictine A and its related compounds, at least in vitro.</description><subject>60 APPLIED LIFE SCIENCES</subject><subject>Alkylation - drug effects</subject><subject>ANIMALS</subject><subject>Antibiotics, Antineoplastic - pharmacology</subject><subject>Antibiotics, Antineoplastic - toxicity</subject><subject>APOPTOSIS</subject><subject>Apoptosis - drug effects</subject><subject>Ascomycota - metabolism</subject><subject>BODY</subject><subject>BROMIDES</subject><subject>BROMINE COMPOUNDS</subject><subject>CALVES</subject><subject>Cancer cells</subject><subject>CATTLE</subject><subject>Cell Cycle - drug effects</subject><subject>Cell death</subject><subject>Cell Line</subject><subject>Cell Line, Tumor</subject><subject>Cell proliferation</subject><subject>Chemical stability</subject><subject>DESORPTION</subject><subject>DICHROISM</subject><subject>DISEASES</subject><subject>DNA</subject><subject>DNA - metabolism</subject><subject>DOMESTIC ANIMALS</subject><subject>DRUGS</subject><subject>FUNGI</subject><subject>GLIOMAS</subject><subject>GLUTATHIONE</subject><subject>Glutathione - metabolism</subject><subject>HALIDES</subject><subject>HALOGEN COMPOUNDS</subject><subject>Hemisyntheses</subject><subject>Heterocyclic Compounds, 3-Ring - pharmacology</subject><subject>Heterocyclic Compounds, 3-Ring - toxicity</subject><subject>Humans</subject><subject>IN VITRO</subject><subject>IONIZATION</subject><subject>LUNGS</subject><subject>LYMPHATIC SYSTEM</subject><subject>MAMMALS</subject><subject>MASS SPECTROSCOPY</subject><subject>MELTING POINTS</subject><subject>Microscopy, Video</subject><subject>NEOPLASMS</subject><subject>Neoplasms - drug therapy</subject><subject>NERVOUS SYSTEM DISEASES</subject><subject>Normal cells</subject><subject>NUCLEIC ACIDS</subject><subject>ORGANIC COMPOUNDS</subject><subject>ORGANS</subject><subject>PEPTIDES</subject><subject>Phyllosticta</subject><subject>Phyllostictines</subject><subject>PHYSICAL PROPERTIES</subject><subject>PLANTS</subject><subject>POLYPEPTIDES</subject><subject>PROTEINS</subject><subject>RADIOPROTECTIVE SUBSTANCES</subject><subject>RESPIRATORY SYSTEM</subject><subject>RESPONSE MODIFYING FACTORS</subject><subject>RUMINANTS</subject><subject>SORPTION</subject><subject>SPECTROSCOPY</subject><subject>Structure-Activity Relationship</subject><subject>STRUCTURE-ACTIVITY RELATIONSHIPS</subject><subject>THERMODYNAMIC PROPERTIES</subject><subject>THYMUS</subject><subject>TOXICITY</subject><subject>TRANSITION TEMPERATURE</subject><subject>VERTEBRATES</subject><subject>Videomicroscopy</subject><issn>0041-008X</issn><issn>1096-0333</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2011</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kc1u1DAUhSMEokPhBVggSyzYNMFOnMSR2FQVP5UqwQIkdtbNzQ3jIWMPtlM1rHgHnoOX4klwNC3sWNmyv3N8fU6WPRW8EFw0L3dFBDgUJRei4FXBy_ZethG8a3JeVdX9bMO5FDnn6vNJ9iiEHee8k1I8zE5KUXPZ1vUm-3Vp2bWJ3jGw0SBYJM8Ao0mHyxmL7sZg2qXbgYXoZ4yzp98_ft4hzNME0TgbtuYQmBvZYbtMkwvJLBpL7PyMAbOQZDAxdwPfIXqDC04Opq9kXUIO3g0z0sD6hcUtsXG2X-bAPvwzAobGB2MeZw9GmAI9uV1Ps09vXn-8eJdfvX97eXF-laMUdcylbKCRYqhVK6q2K-u2bamDXpX9OCIB9qpTPbYENbQKAZoBSWBTDxJkp9rqNHt-9F2f1yElQLhFZy1h1Ck8lQxVol4cqfSBbzOFqPcmIE0TWHJz0KrrRC2apklkeSTRuxA8jfrgzR78ogXXa5d6p9cu9dql5pVOXSbRs1v7ud_T8FdyV14CXh0BSlFcG_LrpJQaHIxfBx2c-Z__H2SItvE</recordid><startdate>20110701</startdate><enddate>20110701</enddate><creator>Le Calvé, Benjamin</creator><creator>Lallemand, Benjamin</creator><creator>Perrone, Carmen</creator><creator>Lenglet, Gaëlle</creator><creator>Depauw, Sabine</creator><creator>Van Goietsenoven, Gwendoline</creator><creator>Bury, Marina</creator><creator>Vurro, Maurizio</creator><creator>Herphelin, Françoise</creator><creator>Andolfi, Anna</creator><creator>Zonno, Maria Chiara</creator><creator>Mathieu, Véronique</creator><creator>Dufrasne, François</creator><creator>Van Antwerpen, Pierre</creator><creator>Poumay, Yves</creator><creator>David-Cordonnier, Marie-Hélène</creator><creator>Evidente, Antonio</creator><creator>Kiss, Robert</creator><general>Elsevier Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7ST</scope><scope>7U7</scope><scope>C1K</scope><scope>M7N</scope><scope>SOI</scope><scope>OTOTI</scope></search><sort><creationdate>20110701</creationdate><title>In vitro anticancer activity, toxicity and structure–activity relationships of phyllostictine A, a natural oxazatricycloalkenone produced by the fungus Phyllosticta cirsii</title><author>Le Calvé, Benjamin ; Lallemand, Benjamin ; Perrone, Carmen ; Lenglet, Gaëlle ; Depauw, Sabine ; Van Goietsenoven, Gwendoline ; Bury, Marina ; Vurro, Maurizio ; Herphelin, Françoise ; Andolfi, Anna ; Zonno, Maria Chiara ; Mathieu, Véronique ; Dufrasne, François ; Van Antwerpen, Pierre ; Poumay, Yves ; David-Cordonnier, Marie-Hélène ; Evidente, Antonio ; Kiss, Robert</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c415t-446a641d587137925777e9ab82bffceacb898bc7ea5a78caa6dce1c65d4a49873</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2011</creationdate><topic>60 APPLIED LIFE SCIENCES</topic><topic>Alkylation - drug effects</topic><topic>ANIMALS</topic><topic>Antibiotics, Antineoplastic - pharmacology</topic><topic>Antibiotics, Antineoplastic - toxicity</topic><topic>APOPTOSIS</topic><topic>Apoptosis - drug effects</topic><topic>Ascomycota - metabolism</topic><topic>BODY</topic><topic>BROMIDES</topic><topic>BROMINE COMPOUNDS</topic><topic>CALVES</topic><topic>Cancer cells</topic><topic>CATTLE</topic><topic>Cell Cycle - drug effects</topic><topic>Cell death</topic><topic>Cell Line</topic><topic>Cell Line, Tumor</topic><topic>Cell proliferation</topic><topic>Chemical stability</topic><topic>DESORPTION</topic><topic>DICHROISM</topic><topic>DISEASES</topic><topic>DNA</topic><topic>DNA - metabolism</topic><topic>DOMESTIC ANIMALS</topic><topic>DRUGS</topic><topic>FUNGI</topic><topic>GLIOMAS</topic><topic>GLUTATHIONE</topic><topic>Glutathione - metabolism</topic><topic>HALIDES</topic><topic>HALOGEN COMPOUNDS</topic><topic>Hemisyntheses</topic><topic>Heterocyclic Compounds, 3-Ring - pharmacology</topic><topic>Heterocyclic Compounds, 3-Ring - toxicity</topic><topic>Humans</topic><topic>IN VITRO</topic><topic>IONIZATION</topic><topic>LUNGS</topic><topic>LYMPHATIC SYSTEM</topic><topic>MAMMALS</topic><topic>MASS SPECTROSCOPY</topic><topic>MELTING POINTS</topic><topic>Microscopy, Video</topic><topic>NEOPLASMS</topic><topic>Neoplasms - drug therapy</topic><topic>NERVOUS SYSTEM DISEASES</topic><topic>Normal cells</topic><topic>NUCLEIC ACIDS</topic><topic>ORGANIC COMPOUNDS</topic><topic>ORGANS</topic><topic>PEPTIDES</topic><topic>Phyllosticta</topic><topic>Phyllostictines</topic><topic>PHYSICAL PROPERTIES</topic><topic>PLANTS</topic><topic>POLYPEPTIDES</topic><topic>PROTEINS</topic><topic>RADIOPROTECTIVE SUBSTANCES</topic><topic>RESPIRATORY SYSTEM</topic><topic>RESPONSE MODIFYING FACTORS</topic><topic>RUMINANTS</topic><topic>SORPTION</topic><topic>SPECTROSCOPY</topic><topic>Structure-Activity Relationship</topic><topic>STRUCTURE-ACTIVITY RELATIONSHIPS</topic><topic>THERMODYNAMIC PROPERTIES</topic><topic>THYMUS</topic><topic>TOXICITY</topic><topic>TRANSITION TEMPERATURE</topic><topic>VERTEBRATES</topic><topic>Videomicroscopy</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Le Calvé, Benjamin</creatorcontrib><creatorcontrib>Lallemand, Benjamin</creatorcontrib><creatorcontrib>Perrone, Carmen</creatorcontrib><creatorcontrib>Lenglet, Gaëlle</creatorcontrib><creatorcontrib>Depauw, Sabine</creatorcontrib><creatorcontrib>Van Goietsenoven, Gwendoline</creatorcontrib><creatorcontrib>Bury, Marina</creatorcontrib><creatorcontrib>Vurro, Maurizio</creatorcontrib><creatorcontrib>Herphelin, Françoise</creatorcontrib><creatorcontrib>Andolfi, Anna</creatorcontrib><creatorcontrib>Zonno, Maria Chiara</creatorcontrib><creatorcontrib>Mathieu, Véronique</creatorcontrib><creatorcontrib>Dufrasne, François</creatorcontrib><creatorcontrib>Van Antwerpen, Pierre</creatorcontrib><creatorcontrib>Poumay, Yves</creatorcontrib><creatorcontrib>David-Cordonnier, Marie-Hélène</creatorcontrib><creatorcontrib>Evidente, Antonio</creatorcontrib><creatorcontrib>Kiss, Robert</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Environment Abstracts</collection><collection>Toxicology Abstracts</collection><collection>Environmental Sciences and Pollution Management</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Environment Abstracts</collection><collection>OSTI.GOV</collection><jtitle>Toxicology and applied pharmacology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Le Calvé, Benjamin</au><au>Lallemand, Benjamin</au><au>Perrone, Carmen</au><au>Lenglet, Gaëlle</au><au>Depauw, Sabine</au><au>Van Goietsenoven, Gwendoline</au><au>Bury, Marina</au><au>Vurro, Maurizio</au><au>Herphelin, Françoise</au><au>Andolfi, Anna</au><au>Zonno, Maria Chiara</au><au>Mathieu, Véronique</au><au>Dufrasne, François</au><au>Van Antwerpen, Pierre</au><au>Poumay, Yves</au><au>David-Cordonnier, Marie-Hélène</au><au>Evidente, Antonio</au><au>Kiss, Robert</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>In vitro anticancer activity, toxicity and structure–activity relationships of phyllostictine A, a natural oxazatricycloalkenone produced by the fungus Phyllosticta cirsii</atitle><jtitle>Toxicology and applied pharmacology</jtitle><addtitle>Toxicol Appl Pharmacol</addtitle><date>2011-07-01</date><risdate>2011</risdate><volume>254</volume><issue>1</issue><spage>8</spage><epage>17</epage><pages>8-17</pages><issn>0041-008X</issn><eissn>1096-0333</eissn><abstract>The in vitro anticancer activity and toxicity of phyllostictine A, a novel oxazatricycloalkenone recently isolated from a plant-pathogenic fungus ( Phyllosticta cirsii) was characterized in six normal and five cancer cell lines. Phyllostictine A displays in vitro growth-inhibitory activity both in normal and cancer cells without actual bioselectivity, while proliferating cells appear significantly more sensitive to phyllostictine A than non-proliferating ones. The main mechanism of action by which phyllostictine displays cytotoxic effects in cancer cells does not seem to relate to a direct activation of apoptosis. In the same manner, phyllostictine A seems not to bind or bond with DNA as part of its mechanism of action. In contrast, phyllostictine A strongly reacts with GSH, which is a bionucleophile. The experimental data from the present study are in favor of a bonding process between GSH and phyllostictine A to form a complex though Michael attack at C=C bond at the acrylamide-like system. Considering the data obtained, two new hemisynthesized phyllostictine A derivatives together with three other natural phyllostictines (B, C and D) were also tested in vitro in five cancer cell lines. Compared to phyllostictine A, the two derivatives displayed a higher, phyllostictines B and D a lower, and phyllostictine C an almost equal, growth-inhibitory activity, respectively. These results led us to propose preliminary conclusions in terms of the structure–activity relationship (SAR) analyses for the anticancer activity of phyllostictine A and its related compounds, at least in vitro.</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>21504755</pmid><doi>10.1016/j.taap.2011.03.027</doi><tpages>10</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0041-008X
ispartof Toxicology and applied pharmacology, 2011-07, Vol.254 (1), p.8-17
issn 0041-008X
1096-0333
language eng
recordid cdi_osti_scitechconnect_21587778
source MEDLINE; Access via ScienceDirect (Elsevier)
subjects 60 APPLIED LIFE SCIENCES
Alkylation - drug effects
ANIMALS
Antibiotics, Antineoplastic - pharmacology
Antibiotics, Antineoplastic - toxicity
APOPTOSIS
Apoptosis - drug effects
Ascomycota - metabolism
BODY
BROMIDES
BROMINE COMPOUNDS
CALVES
Cancer cells
CATTLE
Cell Cycle - drug effects
Cell death
Cell Line
Cell Line, Tumor
Cell proliferation
Chemical stability
DESORPTION
DICHROISM
DISEASES
DNA
DNA - metabolism
DOMESTIC ANIMALS
DRUGS
FUNGI
GLIOMAS
GLUTATHIONE
Glutathione - metabolism
HALIDES
HALOGEN COMPOUNDS
Hemisyntheses
Heterocyclic Compounds, 3-Ring - pharmacology
Heterocyclic Compounds, 3-Ring - toxicity
Humans
IN VITRO
IONIZATION
LUNGS
LYMPHATIC SYSTEM
MAMMALS
MASS SPECTROSCOPY
MELTING POINTS
Microscopy, Video
NEOPLASMS
Neoplasms - drug therapy
NERVOUS SYSTEM DISEASES
Normal cells
NUCLEIC ACIDS
ORGANIC COMPOUNDS
ORGANS
PEPTIDES
Phyllosticta
Phyllostictines
PHYSICAL PROPERTIES
PLANTS
POLYPEPTIDES
PROTEINS
RADIOPROTECTIVE SUBSTANCES
RESPIRATORY SYSTEM
RESPONSE MODIFYING FACTORS
RUMINANTS
SORPTION
SPECTROSCOPY
Structure-Activity Relationship
STRUCTURE-ACTIVITY RELATIONSHIPS
THERMODYNAMIC PROPERTIES
THYMUS
TOXICITY
TRANSITION TEMPERATURE
VERTEBRATES
Videomicroscopy
title In vitro anticancer activity, toxicity and structure–activity relationships of phyllostictine A, a natural oxazatricycloalkenone produced by the fungus Phyllosticta cirsii
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-18T12%3A58%3A54IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_osti_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=In%20vitro%20anticancer%20activity,%20toxicity%20and%20structure%E2%80%93activity%20relationships%20of%20phyllostictine%20A,%20a%20natural%20oxazatricycloalkenone%20produced%20by%20the%20fungus%20Phyllosticta%20cirsii&rft.jtitle=Toxicology%20and%20applied%20pharmacology&rft.au=Le%20Calv%C3%A9,%20Benjamin&rft.date=2011-07-01&rft.volume=254&rft.issue=1&rft.spage=8&rft.epage=17&rft.pages=8-17&rft.issn=0041-008X&rft.eissn=1096-0333&rft_id=info:doi/10.1016/j.taap.2011.03.027&rft_dat=%3Cproquest_osti_%3E899151666%3C/proquest_osti_%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=899151666&rft_id=info:pmid/21504755&rft_els_id=S0041008X11001311&rfr_iscdi=true